Long non-coding RNA NHEG1/hsa-miR-665/HMGB1 axis is involved in the regulation of neuroblastoma progression

References

• Westermann F, Schwab M. Genetic parameters of neuroblastomas. Cancer Lett. 2002;184(2):127–147.
   PubMed Web of Science ®Google Scholar
• Fang E, Wang X, Wang J, et al. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression. Theranostics. 2020;10(4):1555–1571.
   PubMed Web of Science ®Google Scholar
• Villasante A, Sakaguchi K, Kim J, et al. Vascularized tissue-engineered model for studying drug resistance in neuroblastoma. Theranostics. 2017;7(17):4099–4117.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang Q, Jiang X, et al. Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN. Theranostics. 2019;9(4):986–1000.
   PubMed Web of Science ®Google Scholar
• Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202–2211.
   PubMed Web of Science ®Google Scholar
• Barnhill LM, Williams RT, Cohen O, et al. High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma. Cancer Res. 2014;74(14):3753–3763.
   PubMed Web of Science ®Google Scholar
• Yang B, Ye X, Wang J, et al. Long noncoding RNA nuclear-enriched abundant transcript 1 regulates proliferation and apoptosis of neuroblastoma cells treated by cisplatin by targeting miR-326 through Janus kinase/signal transducer and activator of transcription 3 pathway. Neuroreport. 2020;31(17):1189–1198.
   PubMed Web of Science ®Google Scholar
• Yu M, Ohira M, Li Y, et al. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int J Oncol. 2009;34(4):931–938.
   PubMed Web of Science ®Google Scholar
• Li X, Li B, Ran P, et al. Identification of ceRNA network based on a RNA‑seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma. Oncol Lett. 2018;16:5697–5708.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li D, Yang F, et al. Long noncoding RNA NHEG1 drives β-CATENIN TRANSACTIVATION AND NEUROBLASTOMA PROGRESSION THROUGH INTERACTING with DDX5. Mol Ther. 2020;28(3):946–962.
   PubMed Web of Science ®Google Scholar
• Hirai M, Maeda Y, Fukushima K, et al. Expression analysis of microRNAs in murine cochlear explants. Neuroreport. 2011;22(13):652–654.
   PubMed Web of Science ®Google Scholar
• Ling H, Fabbri M, GA C. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847–865.
   PubMed Web of Science ®Google Scholar
• Prashad N. miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth. Oncotarget. 2018;9(69):33186–33201.
   PubMedGoogle Scholar
• Wang T, Tao W, Zhang L, et al. Oncogenic role of microRNA-20a in human multiple myeloma. Onco Targets Ther. 2017;10:4465–4474.
   PubMed Web of Science ®Google Scholar
• Zhao G, Zhang JG, Shi Y, et al. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS One. 2013;8(9):e73803.
   PubMed Web of Science ®Google Scholar
• Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403(6772):901–906.
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524–15529.
   PubMed Web of Science ®Google Scholar
• Tfaily MA, Nassar F, Sellam LS, et al. miRNA expression in advanced Algerian breast cancer tissues. PLoS One. 2020;15(2):e0227928.
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Nishida N, Calin GA, et al. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014;11(3):145–156.
   PubMed Web of Science ®Google Scholar
• Chava S, Reynolds CP, Pathania AS, et al. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol. 2020;14(1):180–196.
   PubMed Web of Science ®Google Scholar
• Nolan JC, Salvucci M, Carberry S, et al. A context-dependent role for MiR-124-3p on cell phenotype, viability and chemosensitivity in neuroblastoma in vitro. Front Cell Dev Biol. 2020;8:559553.
   PubMed Web of Science ®Google Scholar
• Liu J, Jiang Y, Wan Y, et al. MicroRNA‑665 suppresses the growth and migration of ovarian cancer cells by targeting HOXA10. Mol Med Rep. 2018;18(3):2661–2668.
   PubMed Web of Science ®Google Scholar
• Qu Z, Wu J, Wu J, et al. Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis. Oncotarget. 2017;8(46):80666–80678.
   PubMedGoogle Scholar
• Wang S, Du S, Lv Y, et al. MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway. Cancer Manag Res. 2019;11:3111–3123.
   PubMed Web of Science ®Google Scholar
• Zhang S, Long J, Hu Y. Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. Biochem Biophys Res Commun. 2020;526(2):396–403.
   PubMed Web of Science ®Google Scholar
• Yan D, Ma Z, Liu C, et al. Corynoxine B ameliorates HMGB1-dependent autophagy dysfunction during manganese exposure in SH-SY5Y human neuroblastoma cells. Food Chem Toxicol. 2019;124:336–348.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Vlachos IS, Karagkouni D, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44(D1):D231–D238.
   PubMed Web of Science ®Google Scholar
• ÁL R-C, Riquelme I, Brebi-Mieville P. Tools for sequence-based miRNA target prediction: what to choose? Int J Mol Sci. 2016;17(12):1987.
   PubMed Web of Science ®Google Scholar
• Hou M, Wu N, LncRNA YL. CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion. Cancer Cell Int. 2021;21(1):36.
   PubMed Web of Science ®Google Scholar
• Liang M, Wang H, Liu C, et al. LncRNA RUNX1-IT1 is downregulated in endometrial cancer and binds to mir-21 precursor to suppress its maturation. Cancer Manag Res. 2020;12:13451–13459.
   PubMed Web of Science ®Google Scholar
• Song Z, Xie B. LncRNA OIP5-AS1 reduces α-synuclein aggregation and toxicity by targeting miR-126 to activate PLK2 in human neuroblastoma SH-SY5Y cells. Neurosci Lett. 2021;740:135482.
   PubMed Web of Science ®Google Scholar
• Tao HF, Shen JX, Hou ZW, et al. lncRNA FOXP4‑AS1 predicts poor prognosis and accelerates the progression of mantle cell lymphoma through the miR‑423‑5p/NACC1 pathway. Oncol Rep. 2020;45(2):469–480.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Wang FJ, Wang Y, et al. lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback regulatory loop with the miR‑34a/mTOR/SIRT1 pathway in colorectal cancer. Oncol Rep. 2020;45(1):202–216.
   PubMed Web of Science ®Google Scholar
• Guan Y, Li Y, Zhao G, et al. HMGB1 promotes the starvation-induced autophagic degradation of α-synuclein in SH-SY5Y cells Atg 5-dependently. Life Sci. 2018;202:1–10.
   PubMed Web of Science ®Google Scholar
• Mari E, Zicari A, Fico F, et al. Action of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines. Oncol Lett. 2016;12(3):2133–2138.
   PubMed Web of Science ®Google Scholar